Focal adhesion kinase promotes the aggressive melanoma phenotype
- PMID: 16267008
- DOI: 10.1158/0008-5472.CAN-05-2172
Focal adhesion kinase promotes the aggressive melanoma phenotype
Abstract
Malignant melanoma continues to remain a significant health threat, with death often occurring as a result of metastasis. The metastatic phenotype typically is characterized by augmented tumor cell invasion and migration in addition to tumor cell plasticity as shown by vasculogenic mimicry. Therefore, understanding the molecular mechanisms that promote an aggressive phenotype is essential to predicting the likelihood of metastasis at a stage when intervention may be possible. This study focuses on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, including cell survival, invasion, and migration. We found FAK to be phosphorylated on its key tyrosine residues, Tyr397 and Tyr576, in only aggressive uveal and cutaneous melanoma cells, which correlates with their increased invasion, migration, and vasculogenic mimicry plasticity. Additionally, we confirmed the presence of FAK phosphorylated on Tyr397 and Tyr576 in both cutaneous and uveal melanoma tumors in situ. Examination of a functional role for FAK in aggressive melanoma revealed that disruption of FAK-mediated signal transduction pathways, through the expression of FAK-related nonkinase (FRNK), results in a decrease in melanoma cell invasion, migration, and inhibition of vasculogenic mimicry. Moreover, we found that FRNK expression resulted in a down-regulation of Erk1/2 phosphorylation resulting in a decrease in urokinase activity. Collectively, these data suggest a new mechanism involved in promoting the aggressive melanoma phenotype through FAK-mediated signal transduction pathways, thus providing new insights into possible therapeutic intervention strategies.
Similar articles
-
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).Cancer Res. 2001 Apr 15;61(8):3250-5. Cancer Res. 2001. PMID: 11309274
-
Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.Cell Death Differ. 2007 Apr;14(4):818-29. doi: 10.1038/sj.cdd.4402065. Epub 2006 Nov 17. Cell Death Differ. 2007. PMID: 17110957
-
Molecular plasticity of human melanoma cells.Oncogene. 2003 May 19;22(20):3070-5. doi: 10.1038/sj.onc.1206447. Oncogene. 2003. PMID: 12789282 Review.
-
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.Mol Carcinog. 2007 Jun;46(6):488-96. doi: 10.1002/mc.20297. Mol Carcinog. 2007. PMID: 17219439
-
Signal transduction by focal adhesion kinase in cancer.Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4. Cancer Metastasis Rev. 2009. PMID: 19169797 Review.
Cited by
-
Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII.Cancers (Basel). 2020 Oct 17;12(10):3018. doi: 10.3390/cancers12103018. Cancers (Basel). 2020. PMID: 33080820 Free PMC article.
-
Advanced research on vasculogenic mimicry in cancer.J Cell Mol Med. 2015 Feb;19(2):315-26. doi: 10.1111/jcmm.12496. Epub 2015 Jan 19. J Cell Mol Med. 2015. PMID: 25598425 Free PMC article. Review.
-
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.Br J Cancer. 2007 Aug 6;97(3):368-77. doi: 10.1038/sj.bjc.6603884. Epub 2007 Jul 31. Br J Cancer. 2007. PMID: 17667909 Free PMC article.
-
Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.Am J Pathol. 2007 Jan;170(1):1-15. doi: 10.2353/ajpath.2007.060302. Am J Pathol. 2007. PMID: 17200177 Free PMC article. Review.
-
Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.World J Gastrointest Surg. 2010 Apr 27;2(4):117-27. doi: 10.4240/wjgs.v2.i4.117. World J Gastrointest Surg. 2010. PMID: 21160860 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous